Literature DB >> 29752819

Postpolio syndrome and the late effects of poliomyelitis. Part 1. pathogenesis, biomechanical considerations, diagnosis, and investigations.

Julian K Lo1, Lawrence R Robinson1.   

Abstract

Postpolio syndrome (PPS) is characterized by new muscle weakness and/or muscle fatigability that occurs many years after the initial poliomyelitis illness. Many theories exist regarding the pathogenesis of PPS, which remains incompletely understood. In contrast, the late effects of poliomyelitis are often a consequence of biomechanical alterations that occur as a result of polio-related surgeries, musculoskeletal deformities, or weakness. Osteoporosis and fractures of the polio-involved limbs are common. A comprehensive clinical evaluation with appropriate investigations is essential to fulfilling the established PPS diagnostic criteria. PPS is a diagnosis of exclusion in which a key clinical feature required for the diagnosis is new muscle weakness and/or muscle fatigability that is persistent for at least 1 year. Electromyographic and muscle biopsy findings including evidence of ongoing denervation cannot reliably distinguish between patients with or without PPS. Muscle Nerve 58:751-759, 2018.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomechanics; late effects of poliomyelitis; poliomyelitis; postpolio syndrome; rehabilitation

Mesh:

Year:  2018        PMID: 29752819     DOI: 10.1002/mus.26168

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy.

Authors:  Laura H Comley; Rachel A Kline; Alison K Thomson; Victoria Woschitz; Eric Villalón Landeros; Erkan Y Osman; Christian L Lorson; Lyndsay M Murray
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

Review 2.  Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus.

Authors:  Jorge Quarleri
Journal:  Geroscience       Date:  2022-10-19       Impact factor: 7.581

3.  The value of a post-polio syndrome self-management programme.

Authors:  Alexandra Curtis; Jeong Su Lee; Georgios Kaltsakas; Vivian Auyeung; Simon Shaw; Nicholas Hart; Joerg Steier
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

4.  A twelve-week, four-arm, randomized, double-blind, placebo-controlled, phase 2 prospective clinical trial to evaluate the efficacy and safety of an anthroposophic multimodal treatment on chronic pain in outpatients with postpolio syndrome.

Authors:  Ricardo Ghelman; Ivete Y Akiyama; Valeria T de Souza; Jussara Falcão; Vera Orgolini; Jorge K Hosomi; Abrahão A J Quadros; Acary S B Oliveira
Journal:  Brain Behav       Date:  2020-03-11       Impact factor: 2.708

5.  Spinal cord gray matter atrophy is associated with functional decline in post-polio syndrome.

Authors:  Maria Janina Wendebourg; Matthias Weigel; Laura Richter; Vanya Gocheva; Patricia Hafner; Anna-Lena Orsini; Valentina Crepulja; Simone Schmidt; Antal Huck; Johanna Oechtering; Maria Blatow; Tanja Haas; Cristina Granziera; Ludwig Kappos; Philippe Cattin; Oliver Bieri; Dirk Fischer; Regina Schlaeger
Journal:  Eur J Neurol       Date:  2022-03-03       Impact factor: 6.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.